Dear Careina,


I would be cautious of using dyes. Much better to 1) try in-situ
diffraction if possible as this is least invasive or 2) pick a sensible
cryo and just freeze the crystal(s). I would try to same something from
the experiment for seed stock & possibly sequencing.



Dave



David Hargreaves

Associate Principal Scientist

_____________________________________________________________________

AstraZeneca

Discovery Sciences, Structure & Biophysics

Mereside, 50F49, Alderley Park, Cheshire, SK10 4TF

Tel +44 (0)01625 518521  Fax +44 (0) 1625 232693

David.Hargreaves @astrazeneca.com <mailto:name.surn...@astrazeneca.com>



Please consider the environment before printing this e-mail



From: CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] On Behalf Of
Careina Edgooms
Sent: 15 April 2013 11:18
To: CCP4BB@JISCMAIL.AC.UK
Subject: [ccp4bb] salt or not?



Dear ccp4



I have been performing trials on a protein DNA complex for a while now
and have not seen any crystals form. Today I checked an old plate (over
a month old) and I see 4 large crystals. *excitement* Three of them look
tetragonal in shape (like a pyramid) and one of them looks hexagonal. I
do not know if they are salt or protein. There is calcium chloride in
the buffer. They feel quite soft to touch. They do not cause much
birefringence. One of them does not seem to absorb much izit. It did go
a bit blue but not entirely.



How can I tell if this crystal is protein or not? Do you think its worth
trying to see how it diffracts?



Also, does Izit affect diffraction/ protein structures at all? Could I
use a crystal with Izit in a diffraction experiment and ultimately to
get the structure?



Best

Careina


--------------------------------------------------------------------------
AstraZeneca UK Limited is a company incorporated in England and Wales with 
registered number: 03674842 and a registered office at 2 Kingdom Street, 
London, W2 6BD.
Confidentiality Notice: This message is private and may contain confidential, 
proprietary and legally privileged information. If you have received this 
message in error, please notify us and remove it from your system and note that 
you must not copy, distribute or take any action in reliance on it. Any 
unauthorised use or disclosure of the contents of this message is not permitted 
and may be unlawful.
Disclaimer: Email messages may be subject to delays, interception, non-delivery 
and unauthorised alterations. Therefore, information expressed in this message 
is not given or endorsed by AstraZeneca UK Limited unless otherwise notified by 
an authorised representative independent of this message. No contractual 
relationship is created by this message by any person unless specifically 
indicated by agreement in writing other than email.
Monitoring: AstraZeneca UK Limited may monitor email traffic data and content 
for the purposes of the prevention and detection of crime, ensuring the 
security of our computer systems and checking Compliance with our Code of 
Conduct and Policies.

Reply via email to